Patent GB2012162A successfully refreshed from Google Patents.
GB2012162A
Expired / Lapsed
GB
⏱️ 0.0 years remaining
Injectable compositions containing a source of manganous ions for use in the immunotherapy of neoplastic disease
Assignee: Individual
•
Filing: 1978-11-09
•
Granted: —
•
Expires: 1998-11-09
Abstract
Abstract An injectable composition for treating neoplastic disease (cancer) by in situ injection of the cancer comprises a source of manganous ions in an injectable medium. Optional further components of the composition are macromolecular polysaccharides and zinc, calcium, manganese or aluminium triphosphate gels. Suitable sources of Mn<2+> are manganous chloride, carbonate, hydroxide, stearate, guanylate, and hydrogen phosphate gel. The compositions have immunostimulant activity to cause rejection of neoplastic cells.
Inventors
No inventors recorded.
Bibliographic Details
Application Number
—
Jurisdiction
GB
Data Source
google_patents
Last Synchronized
2026-11-05 04:16
CPC Classifications
C; C07; C07H; C07H23/00; A; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61K31/20; A61K33/00; A61K33/24; A61K33/32; C07H21/00
Claims Analysis
Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.